Utah People's Post

The Latest News from the Beehive State

Friday, April 27, 2018
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / New Drug for Liver Cancer: Regorafenib

New Drug for Liver Cancer: Regorafenib

Posted by

liver cancer

The FDA approved a new drug for liver cancer: regorafenib, the first such drug in over a decade.

Medicine evolved a lot over the years as more and more drugs are tested and approved by the FDA. Despite this fact, in the last 10 years, no drug was approved for liver cancer. Until recently, this condition was treated with a drug named sorafenib. Now, the FDA approved a new drug for liver cancer: regorafenib.

Although it has been on the market for quite some time, regorafenib was not approved for liver cancer. This is the first new drug approved by the FDA for liver cancer in the last ten years. Health officials mentioned that they approved this new method based on the fact that there are limited options for people who suffer from this condition.

Researchers mentioned that this new drug could be used by patients who suffer from liver cancer after their original treatment (sorafenib) stopped working. This means that now, liver cancer patients have a new alternative. Since people respond differently to drugs, some might actually recover with the help of regorafenib.

“This is the first time patients with HCC have had an FDA-approved treatment that can be used if their cancer has stopped responding to initial treatment with sorafenib.” said Dr. Pazdur, acting director of the Office of Hematology and Oncology Products.

This drug is an oral multikinase inhibitor already approved for treating metastatic colorectal cancer. It is also used for gastrointestinal stromal tumors that don’t respond to sunitinib or imatinib or are impossible to remove.

Approval for Liver Cancer

A research team carried out a trial study so that the FDA could approve the drug for a new condition. In it, the team monitored 573 patients that suffered from HCC (hepatocellular carcinoma). All of the participants underwent a failed treatment with sorafenib.

The survival rate of the people who received the new drug was 10.6 months. Those who received placebos had an overall survival rate of 7.8 months. This shows that the drug can reduce the risk of death from liver cancer. The disease’s control rate was also bigger with the drug. It was 65.2% with regorafenib and 36.1% with the placebos.

Image source: Vimeo

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health

mm

About

An experienced journalist, who celebrated 20 years since graduating from the University of Montana not so long ago, Jack enjoys tackling crucial world problems. Throughout his career, Jack has gone from writing sports columns to covering world-changing events. “In all these years” -says Jack- “that I fell in love with the media and the freedom it promises”. Jack has a keen interest in the US political scene as well as the tense circumstances of the Middle East.

Like Father, Like Son: Babies Who Look Like Their Dads Get More Attention!

Like Father, Like Son: Babies Who Look Like Their Dads Get More Attention!

By

Alcohol Sales on Sunday No Longer Banned in Indiana

Alcohol Sales on Sunday No Longer Banned in Indiana

By

CDC Doc and Potential Vaccine Whistleblower Vanishes without a Trace

CDC Doc and Potential Vaccine Whistleblower Vanishes without a Trace

By

Nokia, Others Plan to Plant 4G Network on the Moon

Nokia, Others Plan to Plant 4G Network on the Moon

By

ICE Arrests 150 illegal Immigrants in California Despite Mayor’s Early Warning

ICE Arrests 150 illegal Immigrants in California Despite Mayor’s Early Warning

By

Tech-Addicted Kids Lacking Muscle Development to Hold Pencils

Tech-Addicted Kids Lacking Muscle Development to Hold Pencils

By

Eating Fruits and Veggies Can Lower Depression Risk (Study)

Eating Fruits and Veggies Can Lower Depression Risk (Study)

By

Iran Unveils Its First National Cryptocurrency

Iran Unveils Its First National Cryptocurrency

By

New York Is Officially Largest Weed-Smoking City in the World (Study)

New York Is Officially Largest Weed-Smoking City in the World (Study)

By

French Study Suggests Alcohol Abuse Can Boost Dementia Risk

French Study Suggests Alcohol Abuse Can Boost Dementia Risk

By

Grey’s Anatomy May Boost Patients’ Real World Expectations

Grey’s Anatomy May Boost Patients’ Real World Expectations

By

Pages

  • About
  • Contact
  • Privacy Policy
  • Staff
  • Terms and Conditions

Recent Posts

  • Like Father, Like Son: Babies Who Look Like Their Dads Get More Attention!
  • Alcohol Sales on Sunday No Longer Banned in Indiana
  • CDC Doc and Potential Vaccine Whistleblower Vanishes without a Trace
  • Nokia, Others Plan to Plant 4G Network on the Moon
  • ICE Arrests 150 illegal Immigrants in California Despite Mayor’s Early Warning
  • Tech-Addicted Kids Lacking Muscle Development to Hold Pencils
  • Eating Fruits and Veggies Can Lower Depression Risk (Study)

Related Articles

  • Father holding newborn child in his arms

    Like Father, Like Son: Babies Who Look Like Their Dads Get More Attention!

  • Missing CDC Doctor Timothy Cunningham

    CDC Doc and Potential Vaccine Whistleblower Vanishes without a Trace

  • Toddler drawing

    Tech-Addicted Kids Lacking Muscle Development to Hold Pencils

  • Bowl of oatmeal, fresh fruit and nuts

    Eating Fruits and Veggies Can Lower Depression Risk (Study)

  • New York City skyline

    New York Is Officially Largest Weed-Smoking City in the World (Study)

  • Old man eating a sandwich

    French Study Suggests Alcohol Abuse Can Boost Dementia Risk

  • Grey's anatomy cast

    Grey’s Anatomy May Boost Patients’ Real World Expectations

  • Non-stick pan on cooktop

    Non-Stick Pans Can Make You Fat (Study)

  • Young couple on a date

    Many Men on Tinder Use First Dates to Vent, Women Complain

  • Swimmer Plunging into ice-cold water

    British Man Claims Swimming in Ice-Cold Water Cured His Chronic Pain

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2018 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.